Enhanced effects of BMP-binding peptide combined with recombinant human BMP-2 on the healing of a rodent segmental femoral defect

Journal of Orthopaedic Research

Volumn 28, Issue 2, 2010, Pages 258-264

  Morishita, Yuichiro ^a   Naito, Masatoshi ^a   Miyazaki, Masashi ^b   He, Wubing ^b   Wu, Guizhong ^b   Wei, Feng ^b   Sintuu, Chananit ^b   Hymanson, Henry ^b   Brochmann, Elsa J ^c   Murray, Samuel S ^c   Wang, Jeffrey C ^b  

^a FUKUOKA UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

BMP binding peptide (BBP); Osteogenic activity; Recombinant human bone morphogenetic protein 2 (rhBMP 2); Segmental femoral bone defect

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN BINDING PEPTIDE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BONE DEFECT; BONE REMODELING; CONTROLLED STUDY; DISEASE MODEL; DRUG ACTIVITY; FEMORAK DEFECT; FEMORAL DEFECT; FRACTURE HEALING; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMUR; FRACTURE HEALING; FRACTURES, BONE; MALE; MODELS, ANIMAL; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; X-RAY MICROTOMOGRAPHY;

EID: 73849141177     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20970     Document Type: Article

References (20)

1. Riley EH, Lane JM, Urist MR, et al. 1996. Bone morphogenetic protein-2. Biology and applications. Clin Orthop 324:39-46.
2. Rosen V, Thies RS. 1992. The BMP proteins in bone formation and repair. Trends Genet 8:97-102.
3. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, et al. 1990. Recombinant human bone morphogenetic protein induces bone formation (cartilage induction). Proc Nat Acad Sci USA 87:2220-2224.
4. Cook SD, Baffes GC, Wolfe MW, et al. 1994. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop 301: 302-312.
5. Cook SD, Baffes GC, Wolfe MW, et al. 1994. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 76:827-838.
6. Cook SD, Wolfe MW, Salkeld SL, et al. 1995. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 77:734-750.
7. Feighan JE, Davy D, Prewett AB, et al. 1995. Induction of bone by a demineralized bone matrix gel: a study in a rat femoral defect model. J Orthop Res 13:881-891.
8. Gerhart TN, Kirker-Head CA, Kriz MJ, et al. 1993. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 293:317-326.
9. Matsuo T, Sugita T, Kubo T, et al. 2003. Injectable magnetic liposomes as a novel carrier of recombinant human BMP-2 for bone formation in a rat bone-defect model. J Biomed Mater Res 66-A:747-754.
10. Boden SD, Zdeblick TA, Sandhu HS, et al. 2000. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25: 376-381.
11. Boden SD, Kang J, Sandhu HS, et al. 2002. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial. Volvo Award in Clinical Studies. Spine 27:2662.
12. Sakou T. 1998. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22:591.
13. Shields LB, Raque GH, Glassman SD, et al. 2006. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31:542-5547.
14. Vaidya R, Carp J, Sethi A, et al. Complications of anterior cervical discectomy,fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 16, 1257-1265.
15. Behnam K, Phillips ML, Silva JDP, et al. 2005. BMP binding peptide: a BMP-2 enhancing factor deduced from the sequence of native bovine bone morphogenetic protein/non-collagenous protein. J Orthop Res 23:175-180.
16. Urist MR. 1991. Emerging concepts of bone morphogenetic protein. In: Dixon AD, Sarnat BG, Hoyte DAN, editors. Fundamentals of bone growth: methodology and applications. Boston, MA: CRC Press.
17. Urist MR, Chang JJ, Lietz A, et al. 1987. Methods of preparation and bioassay of bone morphogenetic protein and polypeptide fragments. In: Barnes D, Thornhil T, Sirbasda DA, editors. Methods in enzymology. Vol. 146 New York. Academic Press: p 294-312.
18. Alanay A, Chen C, Lee S, et al. 2008. The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion. Spine 33:1709-1713.
19. Hsu WK, Sugiyama O, Park SH, et al. 2007. Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. Bone 40:931-938.
20. Lieberman JR, Daluiski A, Stevenson S, et al. 1999. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 81: 905-917.